Anivive, a software-driven pet health company, today announced the successful completion of its pivotal field study evaluating the safety and effectiveness of LAVERDIA®-CA1 (verdinexor tablets) in ...

Barclays lowered the firm’s price target on 10x Genomics to $18 from $19 and keeps an Overweight rating on the shares. The firm expects the life science tools and diagnostics group to be down ...

20:11 EST Cathie Wood’s ARK Investment buys 120K shares of 10x Genomics (TXG) today Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and ...

The global genomics market is experiencing significant growth, driven by trends in artificial intelligence (AI) and bioengineering. Companies like Complete Genomics, Illumina, and Singular ...

The global genomics market is experiencing significant growth, driven by trends in artificial intelligence (AI) and bioengineering. Companies like Complete Genomics, Illumina, and Singular Genomics ...

Companies like Complete Genomics, Illumina, and Singular Genomics Systems lead the way in next-generation sequencing (NGS), while Eurofins Scientific and PCR Biosystems focus on diagnostics. Cancer, ...

The Plant and Animal Genomics conference recently held in San Diego showcased the ways that rapidly advancing technologies can be used in the crop and livestock sectors ...

This project may inform conservation policy in the face of climate change as one of the species involved in the larger California Conservation Genomics Project (CCGP). This collaborative effort by ...

Colossal is a firm focused on bioscience and the de-extinction of species like the woolly mammoth and dodo bird.

BGI, Complete Genomics, MGI, WuXi AppTec, and WuXi Biologics are obvious targets for The BIOSECURE Act. It is well known that WuXi entities have become dangerously entwined with American biotech.

Distinguished Professor Ian Paulsen, Director of the ARC Centre of Excellence in Synthetic Biology, who co-led the project, says: “By successfully constructing and debugging the final synthetic ...